After the 2019 announcement from UC Physicians CEO Dr. Michael Archdeacon, orthopedic surgeons immediately raised concerns ...

Q1 2026 Earnings Call October 29, 2025 8:01 PM EDTCompany ParticipantsGregory Brown - CEO, MD & DirectorArun Singh ...

Snke OS GmbH has announced the unveiling of SnkeXR, the first medical grade, open platform AR glasses purpose-built for the medical technology industry. The product will be debuted November 4 and 5 at ...

Johnson & Johnson will separate its orthopaedics business to create DePuy Synthes, enhancing strategic focus and stakeholder value. The separation aims to strengthen Johnson & Johnson's focus on ...

Orthopedics is one of the most capital- and equipment-intensive specialties, which some leaders say is driving more development toward single-specialty ASC models. “We’re seeing probably more ...

Along with its third-quarter earnings release on Oct. 14, Johnson & Johnson JNJ announced its intention to separate its Orthopaedics franchise within the MedTech segment. J&J plans to spin off the ...

Erlanger Orthopaedics announces the addition of Reese Courington, MD, to its team of surgeons. "Dr. Courington brings a rare and vital specialty to the region as the only orthopaedic oncologist in the ...

Johnson & Johnson plans to separate its orthopedics segment into its own business within 18 to 24 months, according to an Oct. 14 news release. The company said it expects the move to improve top-line ...

Orthopedics sales generated $9.2 billion last year Company raises 2025 forecast by $300 million Shares drop nearly 2% Oct 14 (Reuters) - Johnson & Johnson (JNJ.N), opens new tab said on Tuesday it ...

Johnson & Johnson said Tuesday it plans to separate its artificial hip and knee business into a stand-alone company to be called DePuy Synthes—the latest attempt to slim down by the healthcare giant.

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Johnson & Johnson will spin out its orthopaedics division as the US-based healthcare group seeks to shift the ...

(Reuters) -Johnson & Johnson on Tuesday raised its 2025 sales forecast after reporting quarterly earnings that topped Wall Street expectations, and announced plans to spin off its orthopedics business ...